CIK 0001447028 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in A1 · fiscal year ends 12/31
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-10-07 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-10-07 | 4 | FORM 4 | 2026-10-01 |
| 2026-10-07 | 4 | FORM 4 | 2026-10-01 |
| 2026-10-07 | 4 | FORM 4 | 2026-10-01 |
| 2026-10-07 | 4 | FORM 4 | 2026-10-01 |
| 2026-10-05 | SCHEDULE 13D/A | SCHEDULE 13D/A | |
| 2026-10-05 | 4 | FORM 4 | 2026-10-01 |
| 2026-10-01 | SC TO-I/A | SC TO-I/A | |
| 2026-09-30 | SC TO-I/A | SC TO-I/A | |
| 2026-09-23 | 4 | FORM 4 | 2026-09-18 |
| 2026-09-23 | 4 | FORM 4 | 2026-09-18 |
| 2026-09-23 | 4 | FORM 4 | 2026-09-18 |
| 2026-09-23 | 4 | FORM 4 | 2026-09-18 |
| 2026-09-04 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-08-24 | SC TO-I | SC TO-I | |
| 2026-08-21 | SC TO-C | SC TO-C | |
| 2026-08-21 | 8-K | FORM 8-K items 8.01,9.01 | 2026-08-21 |
| 2026-08-12 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-08-12 | 10-Q | 10-Q | 2026-06-30 |
| 2026-08-12 | 8-K | FORM 8-K items 2.02,9.01 | 2026-08-12 |
| 2026-07-16 | 8-K | FORM 8-K items 1.02,5.02,8.01,9.01 | 2026-07-15 |
| 2026-06-10 | 4 | FORM 4 | 2026-06-08 |
| 2026-06-10 | 4 | FORM 4 | 2026-06-08 |
| 2026-06-05 | S-8 | S-8 | |
| 2026-05-27 | 8-K | 8-K items 5.02,5.07,9.01 | 2026-05-26 |
Forms on file (last 1,000): 8-K 309, 4 212, 6-K 108, 3 56, 10-Q 38, SC 13D/A 36, SC 13G/A 29, DEFA14A 17. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=ABUS (0.002 USD), /gw/filings/filings?ticker=ABUS&form=8-K, /gw/filings/facts?ticker=ABUS&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange